Matthias Alder's Insider Trades & SAST Disclosures
Matthias Alder's most recent trade in Gain Therapeutics Inc was a trade of 18,750 Restricted Stock Units done . Disclosure was reported to the exchange on March 26, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Matthias Alder.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Gain Therapeutics Inc
|
Matthias Alder | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2024 | 18,750 | 56,250 | - | - | Restricted Stock Units | |
|
Gain Therapeutics Inc
|
Matthias Alder | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2024 | 18,750 | 25,763 | - | - | Common Stock | |
|
Gain Therapeutics Inc
|
Matthias Alder | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.06 per share. | 26 Mar 2024 | 6,085 | 21,140 | - | 4.1 | 24,705 | Common Stock |
|
Gain Therapeutics Inc
|
Matthias Alder | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2024 | 825 | 8,250 | - | - | Restricted Stock Units | |
|
Gain Therapeutics Inc
|
Matthias Alder | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2024 | 825 | 26,588 | - | - | Common Stock | |
|
Gain Therapeutics Inc
|
Matthias Alder | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2024 | 637 | 6,376 | - | - | Restricted Stock Units | |
|
Gain Therapeutics Inc
|
Matthias Alder | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2024 | 637 | 27,225 | - | - | Common Stock | |
|
Gain Therapeutics Inc
|
Matthias Alder | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 370,000 | 370,000 | - | - | Employee Stock Option (right to buy) | |
|
Gain Therapeutics Inc
|
Alder Matthias | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2023 | 637 | 7,013 | - | - | Restricted Stock Units | |
|
Gain Therapeutics Inc
|
Alder Matthias | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2023 | 637 | 5,492 | - | - | Common Stock | |
|
Gain Therapeutics Inc
|
Matthias Alder | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.46 per share. | 20 Dec 2023 | 206 | 5,286 | - | 2.5 | 507 | Common Stock |
|
Gain Therapeutics Inc
|
Matthias Alder | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.50 per share. | 07 Dec 2023 | 1,820 | 4,855 | - | 2.5 | 4,550 | Common Stock |
|
Gain Therapeutics Inc
|
Matthias Alder | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2023 | 3,300 | 9,900 | - | - | Restricted Stock Units | |
|
Gain Therapeutics Inc
|
Matthias Alder | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2023 | 3,300 | 3,300 | - | - | Common Stock | |
|
Gain Therapeutics Inc
|
Matthias Alder | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2023 | 150,000 | 150,000 | - | - | Employee Stock Option (right to buy) | |
|
Gain Therapeutics Inc
|
Matthias Alder | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2023 | 75,000 | 75,000 | - | - | Restricted Stock Units | |
|
Gain Therapeutics Inc
|
Matthias Alder | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2022 | 60,900 | 60,900 | - | - | Employee Stock Option (right to buy) | |
|
Gain Therapeutics Inc
|
Matthias Alder | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2022 | 10,200 | 10,200 | - | - | Restricted Stock Units | |
|
Gain Therapeutics Inc
|
Matthias Alder | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 79,200 | 79,200 | - | - | Employee Stock Option (right to buy) | |
|
Gain Therapeutics Inc
|
Matthias Alder | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 13,200 | 13,200 | - | - | Restricted Stock Units | |
|
Gain Therapeutics Inc
|
Matthias Alder | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2021 | 200,000 | 200,000 | - | - | Non Qualified Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges